ロード中...
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Effective adoptive T cell therapy (ACT) comprises the killing of cancer cells through the therapeutic use of transferred T cells. One of the main ACT approaches is chimeric antigen receptor (CAR) T cell therapy. CAR T cells mediate MHC-unrestricted tumor cell killing by enabling T cells to bind targ...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6470706/ https://ncbi.nlm.nih.gov/pubmed/30875739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20061283 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|